Company: OCEA
Filing Date: 2025-01-13
Form Type: 10-Q
Source: 0001493152-25-001880
Chunk: 4

Company: Ocean Biomedical, Inc.
Filing Date: 2025-01-13
Form: 10-Q
Item: Item 1
Chunk 4
---
 31, 2023 
     35,249,046  
           -  
    $105,292  
    $(196,055) 
    $    (90,763)
  
    Net loss 

     (9,763) 
     (9,763)
  
    Stock-based compensation 
     -  
     -  
     559  
     -  
     559 
  
    Issuance of common stock 
     169,582  
     -  
     1,795  
     -  
     1,795 
  
    Shares issued to vendors 
     50,000  
     -  
     87  
     -  
     87 
  
    Balances at September 30, 2024 
     35,468,628  
     -  
    $107,733  
    $(205,818) 
    $(98,085)

For
the Nine Months Ended September 30, 2023

    Common  
    Additional Paid-In  
    Accumulated  
    Total Stockholders’ 

    Shares  
    Amount  
    Capital  
    Deficit  
    Deficit 
  
    Balances at December 31, 2022 
     17,496,370  
    $        -  
    $70,770  
    $(81,589) 
    $    (10,819)
  
    Balance 
     17,496,370  
    $        -  
    $70,770  
    $(81,589) 
    $    (10,819)

    Retroactive application of reverse capitalization 
     5,859,062  
     -  
     -  
     -  
     - 
  
    Adjusted balance, beginning of period 
     23,355,432  
    $-  
    $70,770  
    $(81,589) 
    $(10,819)
  
    Net loss 
     -  
     -  
        
     (97,610) 
     (97,610)
  
    Net income (loss) 
     -  
     -  
      
     (97,610)